Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Quanex
NX
$959M
| $370K | ﹤0.01% |
16,294
-20,660
| -56% | -$431K |
|
2952
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$189M
| $370K | ﹤0.01% |
14,600
+13,600
| +1,360% | +$335K |
|
2953
Vericel Corp
VCEL
$2.29B
| $370K | ﹤0.01% |
14,676
-23,023
| -61% | -$680K |
|
2954
Coursera
COUR
$1.59B
| $369K | ﹤0.01% |
25,976
-16,084
| -38% | -$287K |
|
2955
Karyopharm Therapeutics
KPTI
$44.2M
| $369K | ﹤0.01% |
5,462
-386
| -7% | -$35.4K |
|
2956
Regenxbio
RGNX
$722M
| $369K | ﹤0.01% |
14,930
-32,616
| -69% | -$815K |
|
2957
Jack in the Box
JACK
$331M
| $368K | ﹤0.01% |
6,560
-10,823
| -62% | -$822K |
|
2958
Toast
TOST
$20.1B
| $366K | ﹤0.01% |
28,343
-44,001
| -61% | -$729K |
|
2959
Tompkins Financial
TMP
$1.44B
| $365K | ﹤0.01% |
5,058
-11,187
| -69% | -$828K |
|
2960
MeiraGTx Holdings
MGTX
$1.18B
| $364K | ﹤0.01% |
48,090
+6,577
| +16% | +$63.8K |
|
2961
DoubleVerify
DV
$1.8B
| $363K | ﹤0.01% |
16,012
+16,002
| +160,020% | +$360K |
|
2962
Vontier
VNT
$4.97B
| $363K | ﹤0.01% |
15,760
+13,243
| +526% | +$339K |
|
|
DPCS
2963
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
| $363K | ﹤0.01% |
+36,522
| New | +$364K |
|
|
MODN
2964
DELISTED
MODEL N, INC.
MODN
| $363K | ﹤0.01% |
14,194
-3,364
| -19% | -$83.8K |
|
2965
Cerus
CERS
$468M
| $362K | ﹤0.01% |
68,466
+774
| +1% | +$3.87K |
|
2966
Employers Holdings
EIG
$908M
| $362K | ﹤0.01% |
8,632
-13,737
| -61% | -$562K |
|
2967
Malibu Boats
MBUU
$562M
| $362K | ﹤0.01% |
6,868
-4,754
| -41% | -$258K |
|
|
RC
2968
Ready Capital
RC
$279M
| $362K | ﹤0.01% |
30,373
-24,020
| -44% | -$338K |
|
2969
RadNet
RDNT
$5.36B
| $360K | ﹤0.01% |
20,835
-19,964
| -49% | -$388K |
|
2970
SunCoke Energy
SXC
$815M
| $360K | ﹤0.01% |
52,951
-33,537
| -39% | -$270K |
|
2971
Standex International
SXI
$4.09B
| $360K | ﹤0.01% |
4,250
-5,629
| -57% | -$527K |
|
2972
Enerpac Tool Group
EPAC
$1.92B
| $359K | ﹤0.01% |
18,872
-29,409
| -61% | -$592K |
|
2973
Sturm, Ruger & Co
RGR
$604M
| $358K | ﹤0.01% |
5,615
-8,808
| -61% | -$592K |
|
|
FRBK
2974
DELISTED
Republic First Bancorp Inc
FRBK
| $357K | ﹤0.01% |
93,714
-4,834
| -5% | -$20.6K |
|
2975
National Beverage
FIZZ
$2.99B
| $356K | ﹤0.01% |
7,281
-11,587
| -61% | -$540K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.